Literature DB >> 10206274

Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations.

J M Boyle1, M J Greaves, R S Camplejohn, J M Birch, S A Roberts, J M Varley.   

Abstract

Radiation-induced G1 arrest was studied in four classes of early passage skin fibroblasts comprising 12 normals, 12 heterozygous (mut/wt) TP53 mutation-carriers, two homozygous (mut/-) TP53 mutation-carriers and 16 strains from nine Li-Fraumeni syndrome or Li-Fraumeni-like families in which no TP53 mutation has been found, despite sequencing of all exons, exon-intron boundaries, 3' and 5' untranslated regions and promoter regions. In an assay of p53 allelic expression in yeast, cDNAs from these non-mutation strains behaved as wild-type p53. Using two different assays, we found G1 arrest was reduced in heterozygous strains with mis-sense mutations and one truncation mutation, when compared to the range established for the normal cells. Heterozygous strains with mutations at splice sites behaved like normal cells, whilst homozygous (mut/-) strains showed either extremely reduced, or no, arrest. Strains from all nine non-mutation families gave responses within the normal range. Exceptions to the previously reported inverse correlation between G1 arrest and clonogenic radiation resistance were observed, indicating that these phenotypes are not strictly interdependent.

Entities:  

Mesh:

Year:  1999        PMID: 10206274      PMCID: PMC2362814          DOI: 10.1038/sj.bjc.6690265

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

Review 1.  Genomic instability due to germline p53 mutations drives preneoplastic progression toward cancer in human cells.

Authors:  M A Tainsky; F Z Bischoff; L C Strong
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

2.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.

Authors:  A Di Leonardo; S P Linke; K Clarkin; G M Wahl
Journal:  Genes Dev       Date:  1994-11-01       Impact factor: 11.361

3.  Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome.

Authors:  T S Davison; P Yin; E Nie; C Kay; C H Arrowsmith
Journal:  Oncogene       Date:  1998-08-06       Impact factor: 9.867

4.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

5.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

7.  A simple p53 functional assay for screening cell lines, blood, and tumors.

Authors:  J M Flaman; T Frebourg; V Moreau; F Charbonnier; C Martin; P Chappuis; A P Sappino; I M Limacher; L Bron; J Benhattar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

9.  Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

Authors:  J M Birch; A L Hartley; K J Tricker; J Prosser; A Condie; A M Kelsey; M Harris; P H Jones; A Binchy; D Crowther
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome.

Authors:  R Mirzayans; R A Aubin; W Bosnich; W A Blattner; M C Paterson
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

View more
  6 in total

1.  Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.

Authors:  J M Varley; G McGown; M Thorncroft; L A James; G P Margison; G Forster; D G Evans; M Harris; A M Kelsey; J M Birch
Journal:  Am J Hum Genet       Date:  1999-10       Impact factor: 11.025

2.  A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition.

Authors:  Isaac P Horn; David L Marks; Amanda N Koenig; Tara L Hogenson; Luciana L Almada; Lauren E Goldstein; Paola A Romecin Duran; Renzo Vera; Anne M Vrabel; Gaofeng Cui; Kari G Rabe; William R Bamlet; Georges Mer; Hugues Sicotte; Cheng Zhang; Hu Li; Gloria M Petersen; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2021-04-03       Impact factor: 5.157

Review 3.  The pathology of familial breast cancer: Clinical and genetic counselling implications of breast cancer pathology.

Authors:  F Lalloo; D G Evans
Journal:  Breast Cancer Res       Date:  1999-10-27       Impact factor: 6.466

4.  Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts.

Authors:  E C Burt; L A James; M J Greaves; J M Birch; J M Boyle; J M Varley
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

5.  The relationship between radiation-induced G(1)arrest and chromosome aberrations in Li-Fraumeni fibroblasts with or without germline TP53 mutations.

Authors:  J M Boyle; A Spreadborough; M J Greaves; J M Birch; J M Varley; D Scott
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

Review 6.  Ionizing radiation-induced responses in human cells with differing TP53 status.

Authors:  Razmik Mirzayans; Bonnie Andrais; April Scott; Ying W Wang; David Murray
Journal:  Int J Mol Sci       Date:  2013-11-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.